ANKRD6 and cancer: Overall, our work identifies a novel signature of 5 genes associated with adverse outcomes in GC, driven specially by 2 of them, ANKRD6 and ITIH3, and reveals for the first time the role of ANKRD6 in metastasis and EMT process, pointing out their potential as a prognostic signature and molecular target in cancer.